ReviewCureus2025
Does Surgery-First Orthognathic Approach Improve Quality of Life of Orthodontic Patients With Skeletal Class III Malocclusion? A Systematic Review Following Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) Guidelines.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Review
- The Benefits of a Surgery-First Approach in Promoting the Psychological Well-Being of Patients with Skeletal Anomalies and Temporomandibular Disorder.Medicina (Kaunas, Lithuania) · 2025Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The surgery-first approach has gained popularity in recent years due to its ability to bypass the presurgical orthodontic phase and significantly reduce treatment duration. However, its broader impact on quality of life and psychosocial outcomes in patients with skeletal class III malocclusion has not been systematically evaluated. This systematic review aimed to assess the effects of the surgery-first approach on quality of life, psychosocial outcomes, and treatment duration in this patient population. The review was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. A comprehensive search of PubMed, Cochrane Library, Scopus, Web of Science, and Embase databases identified studies evaluating the surgery-first approach in skeletal class III patients. Studies addressing the impact of this approach on quality of life, psychosocial outcomes, and treatment duration were included, and the quality of evidence was assessed using the Newcastle-Ottawa Scale. Due to heterogeneity in study designs and outcomes, a narrative synthesis of the data was performed. A total of eight studies, conducted between 2015 and 2022, with 252 participants, met the inclusion criteria. The surgery-first approach demonstrated significant improvements in quality of life, particularly in the early postoperative stages, while avoiding the decline typically observed during the presurgical phase of the conventional orthodontics-first approach. Psychosocial benefits, such as reduced anxiety and enhanced self-esteem, were consistently reported. Treatment duration for the surgery-first approach ranged from 7 to 15 months, significantly shorter than the conventional approach. However, the strength of the evidence was limited by small sample sizes and a lack of randomization in most studies. The surgery-first approach offers distinct advantages for skeletal class III patients, including improved quality of life, enhanced psychosocial outcomes, and shorter treatment duration compared to the conventional orthodontics-first protocol. Nevertheless, further high-quality randomized clinical studies with longer follow-up periods are needed to evaluate long-term outcomes and ensure treatment stability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.